Welcome to our dedicated page for Proassurance Cp news (Ticker: PRA), a resource for investors and traders seeking the latest updates and insights on Proassurance Cp stock.
ProAssurance Cp (PRA) provides specialized insurance solutions for healthcare providers and legal professionals through its property and casualty subsidiaries. This page aggregates official news releases, regulatory updates, and strategic developments from the company.
Investors and industry stakeholders will find timely updates on healthcare liability trends, workers' compensation programs, and innovations in professional liability coverage. Content spans earnings announcements, leadership changes, product expansions, and market positioning updates across PRA's five operational segments.
Key focus areas include developments in medical malpractice insurance, reinsurance strategies through Lloyd's syndicate partnerships, and corporate risk management initiatives. All content is sourced directly from ProAssurance's communications to ensure accuracy and compliance.
Bookmark this page for consolidated access to PRA's latest operational milestones, financial disclosures, and industry-specific insights. Check regularly for objective updates on one of the insurance sector's most specialized providers.
ProAssurance (NYSE:PRA) reported strong Q2 2025 results with net income of $21.9 million ($0.42 per diluted share) and operating income of $26.8 million ($0.52 per diluted share). The company demonstrated significant progress in its medical professional liability and workers' compensation markets.
Key highlights include stable net premiums written of $135.9 million in Medical Professional Liability business, 10% premium increases in Specialty P&C segment, and an 81% retention rate. The consolidated Non-GAAP combined ratio improved by 9.5 percentage points year-over-year. Book value per share increased to $24.80, up from $23.49 at year-end 2024.
The company's pending merger with The Doctors Company received stockholder approval and FTC clearance, with expected closing in H1 2026.
Flagstar Financial (NYSE: FLG) has declared quarterly cash dividends for its common and preferred stocks. The company announced a common stock dividend of $0.01 per share, payable on September 17, 2025, to stockholders of record as of September 7, 2025.
Additionally, the bank declared dividends for three preferred stock series: Series A at $15.94 per share ($0.3984 per depositary share), Series B at $3.3333 per share, and Series D at $3.3333 per share. As of June 30, 2025, Flagstar reported $92.2 billion in assets, $64.4 billion in loans, and $69.7 billion in deposits.
ProAssurance Corporation (NYSE: PRA) and The Doctors Company have achieved a significant milestone in their pending acquisition deal with the early termination of the Hart-Scott-Rodino waiting period by the U.S. Federal Trade Commission on July 2, 2025.
The Doctors Company, the largest physician-owned medical malpractice insurer in the U.S., is set to acquire ProAssurance, a specialty insurer focused on medical liability, medical technology products liability, and workers' compensation insurance. The transaction is expected to close in the first half of 2026, subject to remaining regulatory approvals and other customary closing conditions.
ProAssurance Corporation (NYSE: PRA) announced that stockholders have overwhelmingly approved its proposed acquisition by The Doctors Company, with over 99% of shares voting in favor. The transaction is expected to close in the first half of 2026, subject to regulatory approvals including Hart-Scott-Rodino Act requirements and state insurance regulators' approval.
Upon completion, PRA will delist from NYSE and become a wholly owned subsidiary of The Doctors Company. The merger aims to combine both companies' strengths in the medical professional liability marketplace, with no financing conditions attached.
Flagstar Financial (NYSE: FLG) has declared its quarterly cash dividends for both common and preferred stockholders. The company announced a $0.01 per share dividend on common stock, payable June 17, 2025, to stockholders of record as of June 7, 2025.
Additionally, preferred stock dividends were declared:
- Series A preferred stock: $15.94 per share ($0.3984 per depositary share)
- Series B preferred stock: $3.3333 per share
- Series D preferred stock: $3.3333 per share
As of March 31, 2025, Flagstar reported total assets of $97.6 billion, loans of $67.1 billion, deposits of $73.9 billion, and stockholders' equity of $8.2 billion. The bank operates approximately 400 locations across nine states, focusing on the New York/New Jersey metro area, upper Midwest, Florida, and West Coast.
ProAssurance (NYSE: PRA) will be acquired by The Doctors Company Insurance Group (TDC Group), as announced on March 19, 2025. The transaction is expected to close in the first half of 2026, subject to regulatory approval. Following the acquisition, PRA will be 100% owned by The Doctors Company.
AM Best has confirmed that ProAssurance's Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Ratings of 'a+' (Excellent) remain unchanged, with a stable outlook. The ratings reflect ProAssurance's strongest balance sheet strength, adequate operating performance, favorable business profile, and appropriate enterprise risk management.
The merger combines the fourth-largest medical professional liability (MPL) insurance writer (ProAssurance) with the second-largest (TDC Group) in the United States, based on direct premiums written. AM Best will continue monitoring both organizations independently during the extended transaction period.
AM Best has maintained its ratings for The Doctors Company Insurance Group (TDC Group) following the announcement of their planned acquisition of ProAssurance (PRA). The transaction, announced on March 19, 2025, will combine the second and fourth-largest medical professional liability insurers in the United States.
TDC Group maintains its Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Ratings of 'a+', with a stable outlook. These ratings reflect TDC Group's strongest balance sheet strength, adequate operating performance, neutral business profile, and appropriate enterprise risk management.
The acquisition is expected to close in the first half of 2026, subject to regulatory approval. Upon completion, ProAssurance will become 100% owned by The Doctors Company. AM Best currently anticipates no material changes to TDC Group's rating fundamentals and will continue evaluating both organizations independently during the transaction process.